Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Volta Finance
FY’24: another year of outperformance
11th Sep 2024
Shield Therapeutics Plc
Focusing on successful execution
11th Sep 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
102: EIS is 30! Discussing the past, present and future of the scheme | Christiana Stewart-Lockhart of the EIS Association
Stay up-to-date with the latest research
Sign up to our newsletter
Latest research
Our research can be accessed for free under MIFID.
Find out more >
All research
Corporate research
- Update
- Monthly Report
- Sector Report
Tax advantaged research
- VCT
- EIS
- SEIS
- Initiation
- BR Review
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
List companies
Volta Finance
Investment Companies
FY’24: another year of outperformance
By
Mark Thomas
11 Sep 2024
Shield Therapeutics Plc
Life Sciences
Focusing on successful execution
By
Dr Martin Hall
11 Sep 2024
The TikTok generation are becoming “renegade” investors
05 Sep 2024
The Monthly: September 2024
02 Sep 2024
H&T Group
Financials
1H’24 results: Four-one at half time, but the one wins
By
Mark Thomas
20 Aug 2024
Surface Transforms
Industrial
Pre-close trading, AGM and prospects
By
Mike Foster
13 Aug 2024
City of London Investment Group
Investment Companies
Positive markets add to FUM and maintain dividend
By
Dr Brian Moretta
08 Aug 2024
Renewables
Decisions for infrastructure and renewable energy investors in volatile markets
By
Nigel Hawkins
07 Aug 2024
The Monthly: August 2024
02 Aug 2024
Arbuthnot Banking Group Plc
Financials
1H’24: optimising the franchise value
By
Mark Thomas
30 Jul 2024
Real Estate Credit Investments (RECI)
Investment Companies
Capital Markets Day
By
Mark Thomas
25 Jul 2024
1
2
3
...
82
Next
